Lilly Catalyze360
Lilly Catalyze360 is a comprehensive approach to enabling the early-stage biotech ecosystem, agnostic of the therapeutic area.
Lilly Ventures
An Investor and Strategic Partner to the Global Biotech Ecosystem
Lilly Ventures makes investments to move the innovation needle in novel areas of science, extending to health tech, emerging platforms and other impact initiatives. We deploy customized engagement models to co-invest with world-class syndicate partners and offer counsel and connections within our global network all with the goal of maximizing your company’s scientific impact.
Gateway Labs
Innovation Hubs for Emerging Biotech Companies
With state-of-the-art lab facilities, a full roster of amenities and resources, focused scientific engagement and a shared passion for creating bold breakthroughs, Lilly Gateway Labs is ready and able to propel the speed of your science forward. We have locations in thriving biotech ecosystems around the world.
Lilly ExploR&D
Agile R&D Solutions Supporting Biotechs from Discovery to Clinical Proof-of-Concept
For promising early science to move forward, research and development need to be prioritized. Lilly ExploR&D provides a nimble way to collaborate, offering research and development support that aims to move the best early science forward and remove barriers that slow innovation. Backed by our long-standing legacy and global network, we have offerings and capabilities for every step of the way, from discovery to clinical trials.
Lilly Research & Development
We push the limits of today's science for the promise of delivering tomorrow's medicines.
Lilly Research Award Program
The Lilly Research Award Program provides a pre-competitive collaborative environment in which an external partner can gain invaluable access to our expertise and resources to advance high-risk, high-reward science.
Connect With Us
We're ready to hear more about your promising work and how we can accelerate your science.